Notice Title

Consent to the Distribution of New Medicines

Publication Date
24 Sep 2015

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2015-go5641

Issue Number

104
Title
View PDF
File Type and Size
PDF (22 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Flumazenil 0.1 mg/mL Injection
Flumazenil 0.1mg/mL
Solution for injection
Max Health Limited
Hameln Pharmaceuticals GmbH, Hameln, Germany

Product:
Active Ingredients:

Dosage Form:

New Zealand Sponsor:
Manufacturer:

Trajentamet
Linagliptin 2.5mg
Metformin hydrochloride 500mg
Film coated tablet
Boehringer Ingelheim (NZ) Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany

Product:
Active Ingredients:

Dosage Form:

New Zealand Sponsor:
Manufacturer:

Trajentamet
Linagliptin 2.5mg
Metformin hydrochloride 850mg
Film coated tablet
Boehringer Ingelheim (NZ) Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany

Product:
Active Ingredients:

Dosage Form:

New Zealand Sponsor:
Manufacturer:

Trajentamet
Linagliptin 2.5mg
Metformin hydrochloride 1000mg
Film coated tablet
Boehringer Ingelheim (NZ) Ltd
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany

Dated this 17th day of September 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).